Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study - PubMed (original) (raw)
Comparative Study
. 2009 Apr;104(4):834-42.
doi: 10.1038/ajg.2009.137. Epub 2009 Mar 24.
Affiliations
- PMID: 19319131
- PMCID: PMC2714477
- DOI: 10.1038/ajg.2009.137
Comparative Study
Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study
Zoe R Edelstein et al. Am J Gastroenterol. 2009 Apr.
Abstract
Objectives: Our aim was to measure the relative risks of Barrett's esophagus (BE) associated with demographic factors, measures of adiposity, and smoking among patients with gastroesophageal reflux disease (GERD).
Methods: Patients newly diagnosed with specialized intestinal metaplasia (SIM) (n=197) were compared with patients with GERD (n=418) in a community clinic-based case-control study. Case subgroups included those with any visible columnar epithelium (VBE) (n=97), and those with a long segment (>or=2 cm) of columnar epithelium (LSBE) (n=54).
Results: Risks increased with older age (adjusted odds ratio (aOR) per decade for SIM=1.3, 95% confidence interval (CI)=1.1-1.5; VBE aOR=1.4, CI=1.1-1.6; LSBE aOR=1.5, CI=1.2-1.9), male gender (SIM aOR=1.5, CI=1.1-2.2; VBE aOR=2.7, CI=1.6-4.5; LSBE aOR=3.9, CI=1.9-8.1), and possibly Asian race. Increased risk of BE was observed with high waist-to-hip ratio (WHR, male high: >or=0.9, female high: >or=0.8) (SIM aOR=1.3, CI=0.9-2.1; VBE aOR=1.9, CI=1.0-3.5; LSBE aOR=4.1, CI=1.5-11.4). These associations were independent of body mass index (BMI) for the VBE and LSBE case groups but not for SIM, which was the only case group in which BMI was a significant risk factor. Ever having smoked cigarettes increased risk similarly for all case groups (SIM aOR=1.8, CI=1.2-2.6; VBE aOR=1.6, CI=1.0-2.6; LSBE aOR=2.6, CI=1.3-4.9), although a dose-response relationship was not detected for duration or intensity of smoking.
Conclusions: Older age, male gender, and history of smoking increased risk of SIM and BE among GERD patients independent of other risk factors for BE. Central adiposity was most strongly related to risk of VBE and LSBE. These results may be useful in the development of risk profiles for screening GERD patients.
Conflict of interest statement
CONFLICT OF INTEREST
Guarantor of the article: Thomas L. Vaughan, M.D., M.P.H.
Specific author contributions: All authors participated meaningfully in this study.
Financial support: National Cancer Institute (R01 CA72866; K05 CA124911)
Potential competing interests: None.
Figures
Figure 1
Odds ratios1 for associated with waist-to-hip ratio by case group and gender. 1Adjusted for age, cigarette smoking history and clinic
Similar articles
- Central adiposity and risk of Barrett's esophagus.
Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Edelstein ZR, et al. Gastroenterology. 2007 Aug;133(2):403-11. doi: 10.1053/j.gastro.2007.05.026. Epub 2007 May 21. Gastroenterology. 2007. PMID: 17681161 - The frequency of Barrett's esophagus in high-risk patients with chronic GERD.
Westhoff B, Brotze S, Weston A, McElhinney C, Cherian R, Mayo MS, Smith HJ, Sharma P. Westhoff B, et al. Gastrointest Endosc. 2005 Feb;61(2):226-31. doi: 10.1016/s0016-5107(04)02589-1. Gastrointest Endosc. 2005. PMID: 15729230 - Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus.
Taylor JB, Rubenstein JH. Taylor JB, et al. Am J Gastroenterol. 2010 Aug;105(8):1729, 1730-7; quiz 1738. doi: 10.1038/ajg.2010.194. Epub 2010 May 18. Am J Gastroenterol. 2010. PMID: 20485283 Free PMC article. Review. - Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
Csendes A, Smok G, Quiroz J, Burdiles P, Rojas J, Castro C, Henríquez A. Csendes A, et al. Am J Gastroenterol. 2002 Mar;97(3):554-60. doi: 10.1111/j.1572-0241.2002.05529.x. Am J Gastroenterol. 2002. PMID: 11922546 - The characteristics of Barrett's esophagus: an analysis of 4120 cases in China.
Chen X, Zhu LR, Hou XH. Chen X, et al. Dis Esophagus. 2009;22(4):348-53. doi: 10.1111/j.1442-2050.2008.00924.x. Epub 2009 Jan 23. Dis Esophagus. 2009. PMID: 19191861 Review.
Cited by
- American Gastroenterological Association technical review on the management of Barrett's esophagus.
Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. Spechler SJ, et al. Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13. doi: 10.1053/j.gastro.2011.01.031. Gastroenterology. 2011. PMID: 21376939 Free PMC article. Review. No abstract available. - Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.
Sun X, Chandar AK, Canto MI, Thota PN, Brock M, Shaheen NJ, Beer DG, Wang JS, Falk GW, Iyer PG, Abrams JA, Venkat-Ramani M, Veigl M, Miron A, Willis J, Patil DT, Nalbantoglu I, Guda K, Markowitz SD, Zhu X, Elston R, Chak A. Sun X, et al. PLoS One. 2017 Oct 26;12(10):e0184962. doi: 10.1371/journal.pone.0184962. eCollection 2017. PLoS One. 2017. PMID: 29073141 Free PMC article. - Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus.
Halland M, Katzka D, Iyer PG. Halland M, et al. World J Gastroenterol. 2015 Jun 7;21(21):6479-90. doi: 10.3748/wjg.v21.i21.6479. World J Gastroenterol. 2015. PMID: 26074687 Free PMC article. Review. - Use of the Electronic Health Record to Target Patients for Non-endoscopic Barrett's Esophagus Screening.
Baldwin-Hunter BL, Knotts RM, Leeds SD, Rubenstein JH, Lightdale CJ, Abrams JA. Baldwin-Hunter BL, et al. Dig Dis Sci. 2019 Dec;64(12):3463-3470. doi: 10.1007/s10620-019-05707-2. Epub 2019 Jul 4. Dig Dis Sci. 2019. PMID: 31273597 Free PMC article. - Histologic Features Associated With Columnar-lined Esophagus in Distal Esophageal and Gastroesophageal Junction (GEJ) Biopsies From GERD Patients: A Community-based Population Study.
Soucy G, Onstad L, Vaughan TL, Odze RD. Soucy G, et al. Am J Surg Pathol. 2016 Jun;40(6):827-35. doi: 10.1097/PAS.0000000000000623. Am J Surg Pathol. 2016. PMID: 26927889 Free PMC article.
References
- Heikkinen TJ, Haukipuro K, Koivukangas P, Sorasto A, Autio R, Sodervik H, Makela H, Hulkko A. Comparison of costs between laparoscopic and open Nissen fundoplication: a prospective randomized study with a 3-month followup. J Am.Coll.Surg. 1999 Apr;188(4):368–376. - PubMed
- Myrvold HE, Lundell L, Miettinen P, Pedersen SA, Liedman B, Hatlebakk J, Julkunen R, Levander K, Lamm M, Mattson C, et al. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut. 2001 Oct;49(4):488–494. - PMC - PubMed
- Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology. 2002 May;122(5):1500–1511. - PubMed
- Eloubeidi MA, Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am.J Gastroenterol. 2000 Aug;95(8):1881–1887. - PubMed
Publication types
MeSH terms
Grants and funding
- K05 CA124911/CA/NCI NIH HHS/United States
- T32 CA009168-32/CA/NCI NIH HHS/United States
- R01 CA72866/CA/NCI NIH HHS/United States
- T32 CA009168/CA/NCI NIH HHS/United States
- R01 CA072866-04/CA/NCI NIH HHS/United States
- K05 CA124911-02/CA/NCI NIH HHS/United States
- R01 CA072866/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical